A biophysically realistic computer model of Alzheimer pathology to guide the development of symptomatic drugs
Main Authors: | Roberts Patrick D, Spiros Athan, Geerts Hugo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-07-01
|
Series: | BMC Neuroscience |
Similar Items
-
Impact of amyloid-beta changes on cognitive outcomes in Alzheimer’s disease: analysis of clinical trials using a quantitative systems pharmacology model
by: Hugo Geerts, et al.
Published: (2018-02-01) -
A STRATEGY FOR DEVELOPING NEW TREATMENT PARADIGMS FOR NEUROPSYCHIATRIC AND NEUROCOGNITIVE SYMPTOMS IN ALZHEIMER’S DISEASE
by: Hugo eGeerts, et al.
Published: (2013-04-01) -
Blinded prospective evaluation of computer-based mechanistic schizophrenia disease model for predicting drug response.
by: Hugo Geerts, et al.
Published: (2012-01-01) -
Negative Symptoms in Schizophrenia: Exploring Glutamatergic Modulation Using a Computer-Based Quantitative Systems Pharmacology Approach
by: Hugo eGeerts, et al.
Published: (2014-10-01) -
Toward Predicting Impact of Common Genetic Variants on Schizophrenia Clinical Responses With Antipsychotics: A Quantitative System Pharmacology Study
by: Athan Spiros, et al.
Published: (2021-09-01)